No apparent transmission of transgenic α–synuclein into nigrostriatal dopaminergic neurons in multiple mouse models by Namratha Sastry et al.
RESEARCH Open Access
No apparent transmission of transgenic
α–synuclein into nigrostriatal dopaminergic
neurons in multiple mouse models
Namratha Sastry1,3, Wang Zheng1, Guoxiang Liu1, Helen Wang1,4, Xi Chen1, Michael Cai2,5, Parth Contractor1,6,
Carmelo Sgobio1, Lixin Sun1, Chengsong Xie1 and Huaibin Cai1*
Abstract
Background: α–synuclein (α–syn) is the main component of intracytoplasmic inclusions deposited in the brains of
patients with Parkinson’s disease (PD) and certain other neurodegenerative disorders. Recent studies have explored
the ability of α–syn to propagate between or across neighboring neurons and supposedly “infect” them with a
prion–like mechanism. However, much of this research has used stereotaxic injections of heterologous α–syn fibrils to
induce the spreading of inclusions in the rodent brains. Whether α–syn is able to transmit from the host cells to their
neighboring cells in vivo is unclear.
Methods: Using immunestaining, we examined the potential propagation of α–syn into nigrostriatal dopaminergic
(DA) neurons in three lines of transgenic mice that overexpress human wild–type α–syn (hα–syn) in different
neuron populations.
Results: After testing for three different routes by which hα–syn propagation might occur, we were unable
to find any evidence that hα–syn behaved like a prion and could be transmitted overtime into the DA neurons initially
lack of hα–syn expression.
Conclusions: In transgenic mice hα–syn does not have the ability to propagate at pathologically significant
levels between or across neurons. It must be noted that these observations do not disprove the studies that
show its prion–like qualities, but rather that propagation is not detectable in transgenic models that do not
use any injections of heterologous proteins or viral vectors to induce a spreading state.
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Background
Parkinson’s disease (PD) is the second most common
neurodegenerative disease, causing debilitating motor
and non–motor symptoms [1, 2]. PD is pathologically
characterized by the death of nigrostriatal dopaminergic
neurons in the ventral substantia nigra pars compacta
(SNc) of the midbrain, as well as the presence of intracy-
toplasmic inclusions known as Lewy bodies (LBs) and
Lewy neurites (LNs). The main component of these in-
clusions is α–synuclein (α–syn) [3]. α–syn is a small 140
amino acid protein that is thought to play a role in syn-
aptic vesicle release [4]. Both missense and multipli-
cation mutations of α–syn are linked to early onset
familial forms of PD [5]. How mutant α–syn leads to
SNc DA neuron loss and LB/LN formation has been
under intense investigation ever since.
PD patient brains seem to show a stereotypical appear-
ance of LB/LN pathology that can be mapped into vari-
ous stages of disease evolution: lesions first appear in the
glossopharyngeal and vagal nerves, continue to the SNc
DA neurons, and eventually cover the primary sensory
and motor cortices [6]. Subsequent studies have hypoth-
esized that α–syn intercellular propagation may be re-
sponsible for this stereotypical pathology and have
provided evidence both in vitro and in vivo [7–10]. The
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in vivo studies have primarily focused on using intra-
cerebral inoculations of diseased brain homogenate or
preformed α–syn fibrils to study development and
progression of PD pathology [9, 10]. In wild–type
control mice, injections of preformed fibrils of α–syn
are sufficient to initiate LB/LN pathology in regions
anatomically connected to the site of injection [9].
Such intracerebral injections can also accelerate the
formation of LBs and LNs in otherwise asymptotic
mice [10] and can be seen over serial passages of in-
oculations [11]. This has been further confirmed by a
study where inoculation with homogenate from either
A53T human α–syn transgenic mouse brains or mul-
tiple system atrophy patient brains resulted in disease
pathology in mice that do not otherwise develop any
spontaneous illness [12]. Moreover, this phenomenon
has been studied in primates, and propagation is evi-
dent in macaque monkeys in addition to rodents [13].
Increasing evidence thus suggests that α–syn poten-
tially behaves in a prion–like manner, where mutated
α–syn can be transmitted from cell to cell and spread
the pathology [14].
While these studies provide very compelling results
to show the prion–like qualities of α–syn, much of the
methodology involves artificial injections and inocula-
tions. This triggered us to determine if α–syn propaga-
tion could be observed in mice that overexpress human
wild–type α–syn (hα–syn), without the need for any
injections. Therefore, we generated multiple lines of
transgenic mice that overexpress hα–syn in different
neuron populations inside and outside of the SNc. We
then examined three different routes by which α–syn
may propagate into the SNc DA neurons, including
long–range propagation from anatomically separated
regions, short–distance transmission from presynaptic
spiny projection neurons (SPNs), and neighboring DA
neurons. Unlike previous inoculation experiments, we
found no evidence that α–syn could propagate and pos-
sess prion–like qualities in any of our three modes of
study, thus questioning α–syn propagation as the method
of disease progression in PD.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health.
The protocol was approved by the Institutional Animal
Care and Use Committees of the National Institute of
Child Health and Human Development, NIH (Permit
Number: 13–040). All surgery was performed under keta-
mine anesthesia, and all efforts were made to minimize
suffering.
Animals
To generate tetO–SNCA transgenic mice, human wild–
type α-syn (SNCA) cDNA coding region was inserted
into the mouse prion protein (pPrP)–tetO gene expres-
sion vector (a gift from Dr. David Borchelt, University
of Florida, Gainesville, FL), which is controlled by the
tetracycline-responsive promoter (tetP) [15]. The tetO-
SNCA expression construct was then purified and micro-
injected into fertilized oocytes derived from C57BL/6 J
mice. The founder mice were crossed with wild-type
C57BL/6 J mice to produce the F1 generation. Pitx3–tTA
knock–in mice were created as described previously [16].
Drd1a–rtTA mice were obtained from Jackson Laborator-
ies (Bar Harbor, ME). All mice were housed in a 12 h
light/dark cycle and fed regular diet ad libitum. All mouse
work follows the guidelines approved by the Institutional
Animal Care and Use Committees of the National Insti-
tute of Child Health and Human Development, NIH.
Genotyping
Genomic DNA was prepared from tail biopsy using
DirectPCR Lysis Reagent (Viagen Biotech, Inc., Los
Angeles, CA) and subjected to PCR amplification using
specific sets of PCR primers for each genotype, including
Pitx3–tTA transgenic mice (Pitx3–F: GACTGGCTTG
CCCTCGTCCCA and Pitx3–R: GTGCACCGAGGCCC-
CAGATCA), tetO–SNCA transgenic mice (PrpEx2–F:
TACTGCTCCATTTTGCGTGA and SNCA–R: TCCAG
AATTCCTTCCTGTGG), Drd1a–rtTA transgenic mice
(14915–F: ACCGGAAGTGCTTTCCTTCT and 14916–R:
CGACTTGATGCTCTTGATCTTCC).
Immunohistochemistry and light microscopy
Mice were sacrificed and then perfused via cardiac infu-
sion with 4 % paraformaldehyde in cold PBS, followed
by post–fixation in the same solution overnight. To
obtain sections, brain tissues were removed and sub-
merged in 30 % sucrose for 24 h and sectioned at
30 μm thickness using a cryostat (Leica CM1950,
Buffalo Grove, IL). Antibodies specific to TH (rabbit
polyclonal, 1:1000, Pel–Freez, Rogers, AR), human α–
synuclein (mouse monoclonal, syn211, 1:500, Santa
Cruz Biotech, Santa Cruz, CA) were used as suggested
by manufacturers. Alexa 488 and Alexa 546–conjugated
secondary antibodies (1:500, Life Technologies, Grand
Island, NY) were used to visualize the staining. Fluores-
cence images were captured using a laser scanning con-
focal microscope (LSM 510; Zeiss, Thornwood, NJ).
The images were presented as either a single optic layer
after acquisition in z–series stack scans at 2–3 μm in-
tervals from individual fields or displayed as maximum
intensity projections to represent confocal stacks.
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Image analysis
For the quantitative co–localization assessments, images
from serial sections were taken and exported to ImageJ
(NIH, Bethesda, MD) for imaging analyses. Each image
was split into individual channels for SNCA (488 nm)
and TH (546 nm). Cell bodies positive for TH were first
selected using the polygon selection tool and then sub-
jected to measurement by mean optical intensities. The
mean intensities were then compared to the identical re-
gions in SNCA channel. SNCA intensities below a set
threshold were counted as being negative. The overall
percentages of positive SNCA cells were then compared
between the ages of 1 m and 16–18 m.
Stereology
According to the mouse brain in stereotaxic coordinates
(3rd edition, Keith B.J. Franklin and George Paxinos), a
series of coronal sections across the midbrain (30 μm
per section, every fourth section from Bregma −2.54 mm
to −4.24 mm) were chosen and processed for TH stain-
ing as described above and visualized using a widefield
microscope (Axio Imager A1; Zeiss). We examined 16
sections per brain at 40x magnification. The number of
TH positive neurons was assessed using the Optical
Fractionator Workflow in Stereo Investigator 11 (Micro-
BrightField Inc, Williston, VT). The sampling scheme
was designed to have coefficient of error (CE) less than
10 % in order to get reliable results. A pilot counting of
samples was performed to achieve a total marking of
>200 cells, which generally yields CE <10 %. Once the
pilot cells counting had completed, the CE was calcu-
lated. The counting parameters would be adjusted based
on the CE value. To achieve CE <10 %, normally 12
series sections with total 100 counting frames and on
average 2 cells per frame would be counted. The final
parameters for these studies were: grid size 150x120μm
and frame size 50x50μm. Three or more mice were used
per genotype at each time point.
Tissue fractionation and Western blot
Striatum tissues were homogenized with 10 volumes of
sucrose buffer (0.32 M sucrose, 1 mM NaHCO3, 1 mM
MgCl2, and 0.5 mM CaCl2, plus protease and phosphat-
ase inhibitor cocktails) and centrifuged at 10,000 g for
10 min. Protein concentrations in supernatant were
measured by BCA (Thermo Fisher Scientific). Proteins
were size–fractioned by 4–12 % NuPage BisTris–
polyacrylamide gel electrophoresis (Life Technologies)
using MES running buffer (Life Technologies). After
transfer to nitrocellulose membranes, the membranes
were immunoblotted with the appropriate dilutions of
the primary antibody: human α–syn (syn211, 1:1000;
Santa Cruz Biotechnology, Santa Cruz, CA) and α–tubulin
(DM1A, 1:2000; Santa Cruz Biotechnology, Santa Cruz,
CA. Signals were visualized with fluorescent secondary
antibodies and quantified with ImageJ.
Statistical analysis
Statistical analysis was performed using Graphpad Prism
5 (Graphpad Software Inc. La Jolla, CA). Data were pre-
sented as mean ± SEM. Statistical significances were de-
termined by comparing means of different groups and
conditions using unpaired Student t–test or one–way
ANOVA with post hoc Tukey test.
Results
Transgenic hα–syn is unable to undergo long–range
propagation
We generated a new line of human wild–type α–syn
(SNCA) transgenic mice under the control of tetracyc-
line operator (tetO): tetO–SNCA. The expression of
transgenic SNCA assumes to be regulated by the tetra-
cycline transactivator (tTA) in a “tet–off” gene expres-
sion system [17]. However, immunostaining revealed
substantial expression of hα–syn in multiple brain re-
gions, including the hippocampus, cerebellum, and cor-
tex, independent of tTA (Fig. 1a). Our first test for
propagation utilized the “leaky” expression of hα–syn
present in tetO–SNCA transgenic mice. We wanted to
see whether the tyrosine hydroxylase (TH)–positive SNc
DA neurons that were initially devoid of hα–syn (Fig. 1a)
would show any hα–syn accumulation with age. Poten-
tially, these other tissues or residual hα–syn from the
cerebrospinal fluid can aid in “infecting” the SNc DA
neurons. If propagation can occur in this long–range
fashion, hα–syn might accumulate in SNc DA neurons
at advanced ages. We checked for this expression at 1
and 18 months of age (Fig. 1b). At 1–month–old, we
found a few hα–syn–positive puncta distributed in the
SNc region; some were spotted inside of SNc DA neu-
rons (Fig. 1b, inset). Any additional hα–syn present at
later ages would have been evidence for propagation.
However, at 18 months of age, we were unable to see
any apparent propagation (Fig. 1b). The lack of any sub-
stantial accumulation of hα–syn in the SNc DA neurons
indicates that no long–range propagation is evident for
tetO–SNCA mice.
Since the transcription factor paired–like homeodo-
main 3 (Pitx3) is only expressed by subpopulations of
midbrain DA neurons [18], previously we inserted tetra-
cycline transactivator (tTA) coding sequence into the
3’–untranslated region of mouse Pitx3 gene to gener-
ate Pitx3–tTA knock–in mice, allowing tTA selectively
expressed in midbrain DA neurons [16]. In this so–called
“tet–off” system, tTA can turn on the expression of any
transgene under the control of tetracycline operator (tetO)
[16]. In the absence of such a transgene, this line of mice
has no transgenic expression in the midbrain (Fig. 1a, b).
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Thus, to test whether hα–syn would induce the ag-
gregation of endogenous mouse α–syn (mα–syn) in
SNc DA neurons, we stained the midbrain sections of
18–month–old tetO–SNCA single transgenic and Pitx3–
tTA heterozygous knock–in mice with an antibody that
recognizes both mouse and human α–syn (m/hα–syn).
We observed a similar number of small m/hα–syn–posi-
tive puncta in the SNc DA neurons of tetO–SNCA and
control Pitx3–tTA mice (Fig. 1c), indicating a lack of re-
cruitment of endogenous α–syn. Together, these ob-
servations suggest a lack of long–range transneuronal
propagation of transgenic hα–syn into SNc DA neu-
rons during aging.
α–synuclein is not transmitted from presynaptic terminals
into SNc DA neurons
We next examined the transmission between anatomic-
ally connected brain regions, specifically the SNc and
striatum in the basal ganglia. The majority of DA neu-
rons in the SNc send projections to SPNs in the striatum
[19]. SPNs comprise two main subpopulations that form
direct and indirect pathways in the basal ganglia [19]. In
the direct pathway, most SPNs that express dopamine
receptor D1 (Drd1) send projections to neurons at sub-
stantia nigra pars reticulata (SNr), while some directly
form synapses with SNc DA neurons [20, 21]. To further
investigate propagation in the direct pathway, we used a
line of mice that utilizes a reverse tetracycline transacti-
vator (rtTA) and the Drd1a promoter, which directs
transgene expression in the SPNs of direct pathway.
When crossed with tetO–SNCA mice, we expect to see
hα–syn expression along the direct pathway. Indeed at 1-
month-old, Drd1–rtTA/tetO–SNCA mice showed strong
hα–syn expression in the striatum and SNr, but no ex-
pression in the SNc (Fig. 2a). Once again, hα–syn expres-
sion at later ages would indicate that propagation is
Fig. 1 No propagation of α-syn into the nigrostriatal DA neurons of tetO–SNCA single transgenic mice. a Sample images show the expression
pattern of hα-syn (green) in the sagittal sections of 1–month–old tetO–SNCA mice. DA neurons were marked by TH staining (red). Topro3 was
used for counter–staining (blue). CX; cerebral cortex; HIP: hippocampus; CB: cerebellum; STR: striatum; SNc: substantia nigra pars compacta. Scale
bar: 1 mm. b Sample images show the staining of hα-syn (green) and TH (red) in the SNc of 1– and 18–month–old tetO–SNCA mice. Insets highlight
the boxed area. Arrowheads point to the hα-syn–positive puncta. SNr: substantia nigra pars reticulata. Scale bar: 100 μm. c Sample images show the
staining of m/hα-syn (green) and TH (red) in the SNc of 18–month–old tetO–SNCA single transgenic and Pitx3–tTA heterozygous knock-in
mice. Arrowheads point to the hα-syn–positive puncta. Scale bar: 10 μm
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present. We then looked at 12–month-old mice and found
that they too had no hα–syn–positive cells present in the
SNc (Fig. 2b). As seen with the tetO–SNCA mice (Fig. 1b
and c), small hα–syn–positive puncta were observed near
or on top of SNc DA neurons (Fig. 2b). These puncta were
also positive for synaptophysin, a marker for presynaptic
terminals [22] (Fig. 2c), indicating a presynaptic enrich-
ment of α–syn as previously documented [23]. The same
as the previous experiments, we again found no indication
that hα–syn possesses the ability to propagate across the
synapses.
α–synuclein is unable to undergo cell–to–cell
transmission between SNc DA neurons
We finally examined α–syn propagation within SNc DA
neurons. To express SNCA in the midbrain, we cross-
bred Pitx3–tTA heterozygous knock–in mice with
tetO–SNCA heterozygous transgenic mice to generate
Fig. 2 α-synuclein is not transmitted in anatomically connected regions. a In the top panel, sample image shows the expression pattern of
hα-syn (green) and TH (red) in the sagittal sections of 1–month–old Drd1a–rtTA::tetO–SNCA bigenic mice. Topro3 was used for counter–staining
(blue). In the bottom left panel, arrowheads point to Drd1–type striatal neurons that express hα-syn. The bottom right panel highlights the boxed area
in the top panel. Scale bar: 1 mm. b Sample images show the staining of hα-syn (green) and TH (red) in the SNc of 1– and 18–month–old Drd1a–rtTA::-
tetO–SNCA bigenic mice. Arrowheads point to the hα-syn–positive puncta. Scale bar: 10 μm. c Sample image shows the staining of hα-syn
(green), synaptophysin (red) and TH (blue) in the SNc of 18–month–old Drd1a–rtTA::tetO–SNCA bigenic transgenic mice. The panels at the
top and right depict the distribution of different fluorophores along the Y– and X–axis. Scale bar: 10 μm
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Pitx3–tTA::tetO–SNCA bigenic mice. The cells express-
ing hα–syn co–localize well with TH in the SNc in
these mice (Fig. 3a). We subsequently examined co–
localization patterns in the Pitx–tTA::tetO–SNCA
bigenic mice that expressed hα–syn in midbrain DA
neurons and (Fig. 3b-d). We looked at mice that were
1– and 16–18–month–old to determine how co–
localization values changed with age. Pitx3 is mainly
expressed in the ventral SNc DA neurons, but not in
the dorsal ones that account for about 20 % of total DA
neuron population [24]. In our study, this translated to
~80 % of the TH–positive SNc cells expressing hα–syn
under the control of the Pitx3 promoter (Fig. 3d). We
wanted to see if this percentage would increase with
age, indicating the presence of cell–to–cell transmis-
sion of hα–syn in these cells. Contrary to what would
Fig. 3 α-syn is unable to undergo cell–to–cell transmission at SNc. a Sample images show the expression pattern of hα-syn (green) and TH (red)
in the sagittal sections of 1–month–old Pitx3–tTA::tetO–SNCA bigenic mice. Topro3 was used for counter–staining (blue). Scale bar: 1 mm.
b Sample images show the staining of hα-syn (green) and TH (red) in the SNc of 1– and 16–month–old Pitx3–tTA::tetO–SNCA bigenic
mice. Scale bar: 100 μm. c Images highlight the boxed areas in b. Arrowheads point to the hα-syn–negative DA neurons. d Scatter plot
depicts co-localization percentages at 1 month and 16 months. Data were presented as mean ± SEM. *P < 0.05
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be expected for propagation, we found that the average
percentage of co–localized cells at 1–month–old was
83.3 %, whereas the percentage at 16–18–month–old
was 77.6 % (Fig. 3d). As we did not see the increase that
indicates the presence of propagation, this experiment
provided no evidence for local propagation between
neighboring SNc DA neurons.
In addition to tissue staining, Western blotting re-
vealed more than 5–fold increase of α–syn expression
in cerebellum of tetO-SNCA single and Pitx3–tTA::-
tetO–SNCA double transgenic mice (Fig. 4a). Further-
more, α–syn–positive high molecular weight (HMW)
bands were also detected in the whole brain homoge-
nates of tetO-SNCA single, Pitx3–tTA::tetO–SNCA,
and Drd1–rtTA::tetO-SNCA double transgenic mice
(Fig. 4b), suggesting the existence of α–syn aggregates
in the mouse brains of all the transgenic lines. West-
ern bolting also showed the hα–syn expression was
substantially increased in the striatum of Pitx3–tTA::-
tetO–SNCA double transgenic mice compared to the
tetO-SNCA single animals (Fig. 4c), resulting from the
projection of hα–syn–expressing DA axons at the
striatum (Fig. 3a).
Discussion
We show here that transgenic hα–syn does not show
detectable propagation to nigrostriatal DA neurons in
various mouse models. We first used tetO–SNCA sin-
gle transgenic mice to show that we could not ob-
serve long–range propagation of hα–syn into SNc DA
Fig. 4 Overexpression of hα-syn in tetO-SNCA single and Pitx3–tTA::tetO–SNCA bigenic mice. a Western blots show expression of hα-syn and
m/hα-syn in the cerebellum of 1–month–old tetO-SNCA single and Pitx3–tTA::tetO–SNCA bigenic mice. α-tubulin was used as loading control. Bar
graphs depict the signal intensity. Data were presented as mean ± SEM. b Western blot shows expression of hα-syn and m/hα-syn in the whole
brain of 18–month–old Pitx3–tTA, tetO-SNCA single, Drd1a–rtTA::tetO–SNCA bigenic and Pitx3–tTA::tetO–SNCA bigenic mice. β-actin was used as
loading control. c Western blots show expression of hα-syn and m/hα-syn in the striatum of 1–month–old tetO-SNCA single and Pitx3–tTA::tetO–SNCA
bigenic mice. α-tubulin was used as loading control. Bar graphs depict the signal intensity. Data were presented as mean ± SEM
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neurons. These mice have no transgenic hα–syn ex-
pression in the nigrostriatal pathway; however, they
do have “leaky”, non–specific hα–syn expression in
other brain regions (i.e. hippocampus, cortex, and
cerebellum). Any of these other regions could have
played a role being a source of α–syn if the protein
could indeed propagate. We performed immunohisto-
chemical experiments on young and aged mice to see
if we can observe hα–syn–positive staining anywhere
in the SNc DA neurons of aged animals. However,
these experiments gave no indication that long–range
propagation was present in SNCA mice.
The following experiment tested propagation that may
occur through neuronal projections from neighboring
brain regions. For these experiments, we utilized a line
of mice, Drd1a–rtTA::tetO–SNCA, which had hα–syn
expression in the striatum and SNr, modeling the direct
pathway of the basal ganglia. At 1–month of age, these
mice exhibited no hα–syn expression in the SNc DA
neurons. If propagation was present, we should be able
to see hα–syn expression at later ages in these mice.
This may have occurred as transmission directly to the
SNc from the SPNs that form synapses onto SNc DA
neurons [21]. However, as with the previous experi-
ments, we found no evidence of hα–syn being present in
the SNc, again showing that there was no evident
propagation.
Finally, we looked at Pitx3–tTA::tetO–SNCA bigenic
mice, which utilize the Pitx3 driver to promote hα–syn
expression along the nigrostriatal pathway, in addition to
the leaky expression patterns seen in the tetO–SNCA
single transgenic mice. Following the expression pat-
tern of Pitx3, we found that ~80 % of cells were both
hα–syn–positive and TH–positive in 1–month–old
bigenic mice. An increase in this percentage in aged
mice would indicate that more cells were becoming
hα–syn–positive, thus giving evidence for cell–cell
transmission of α–syn. While there was about 50 %
loss of SNc DA neurons in Pitx3–tTA::tetO–SNCA
bigenic mice compared to Pitx3–tTA knock-in mice,
no further degeneration occurred between 1–month
and 16–18–month–old bigenic mice (Fig. 5a–b). Thus
any increase could be attributed to the spread of α–syn, as
opposed to cell death that may have resulted from α–syn
toxicity. Instead of seeing the increase that would in-
dicate propagation, we actually saw a slight decrease.
However, the lack of degeneration led us to conclude
that this decrease likely has no actual significance in
the pathogenesis.
Conclusion
Many studies have shown the ability of α–syn to
propagate with the use of stereotaxic injections of
preformed fibrils and have provided very convincing
data for the ability of α–syn to behave as a prion,
both in neurons and in glial cells [14]. However, these
studies often take advantage of artificial injections or
inoculations, which may not be as applicable in a
clinical, physiological setting. Therefore, alternative
explanations to the prion hypothesis cannot be dis-
missed, including oxidative stress, excitotoxicity, neu-
roinflammation, and loss of neurotrophic factor support.
Fig. 5 Loss of DA neurons in the SNc of Pitx3–tTA::tetO–SNCA bigenic mice. a Sample images show the staining of TH (brown) in the SNc of
16–month–old Pitx3–tTA heterozygous knock-in and Pitx3–tTA::tetO–SNCA bigenic mice. Scale bar: 100 μm. b Scatter plot depicts the number of
remaining TH–positive neurons in the SNc of 1 month and 16–18 months. Data were presented as mean ± SEM. ***P < 0.001
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These alternative explanations are not mutually exclusive
and may potentially induce pathogenesis in a synergistic
manner. Future studies should focus on microglial activa-
tion and other inflammatory responses in the brain result-
ing from intracerebral injections and inoculations. In
addition, further scrutiny into the effect of inflammation
on α–syn expression can provide answers about the
causes and mechanisms by which α–syn adopts its abnor-
mal prion–like qualities.
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